Skip to content

Hypoglycemic Effect Using Ayurveda Treatment For The Management Of Madhumeha(Diabetes Mellitus Type 2)

Assessment Of Hypoglycemic Effect Using Holistic Approach Of Ayurveda Protocol For The Management Of Prameha/Madhumeha With Special Reference To DM Type 2 Using Different Dosages Pattern: A Therapeutic Clinical Trial - AHHAPMPMDM

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/01/030636
Enrollment
80
Registered
2021-01-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Nishakathakadi Kwatha Mamajjaka Ghana Vati Gokshuradi guggulu: Mild cases Nishakatakadi Kwatha 40 ml BD Gokshuradi Guggulu 500 mg BD Mamajjaka Ghana Vati 500 mg Tab BD Each medicine B

Sponsors

All India Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of either gender in the age group of 25-65years. 2. Patients with classical signs and symptoms of Prameh/Madhumeha viz Prabhuta Mutrata, Avila Mutrata, Pipasadhikya, Alasya, Utsahahani, Kshudhadhikya, Pindikodveshthana, Karapadatala Suptata, Daurbalya, Nidradhikya and Purishabadhdhata. 3. Patients with random blood sugar level (RBS) >200 mg/dl up to 450 4. Fasting blood sugar (FBS) >110 mg/dl up to 300 mg/dl 5. Postprandial blood sugar (PPBS) >140 mg/dl up to 450 mg/dl 6. Glycosylated haemoglobin > 6.5%. 7. Newly /early diagnosed cases to be included as per following criteria: i. Patients who are not taking any conventional medicine for more than two months, whose sugar levels are raised and fall within the inclusive criteria mentioned above and are willing to take Ayurvedic treatment. ii. Patient accidently diagnosed in routine check-up or when appeared with other complaints in the hospital. iii. Early diagnosed diabetic patients (less than 2yr of diabetic history) and not taking any pharmacological drugs since last two months

Exclusion criteria

Exclusion criteria: 1. Patients having insulin dependent DM (type 1) and receiving insulin / OHA 2. Excessive blood glucose: FBS > 300 mg/dl and PPBS > 450 mg/dl 3. Emergency conditions in cases of DM. 4. Patients with acute/chronic liver disease with elevated liver enzymes. 5. Chronic complications like microvascular and macrovascular derangements. 6. Hyperthyroidism or hypothyroidism 7. Patients reporting to be hypersensitive to any of the proposed trial drugs. 8. Pregnant women/ lactating mothers 9. Participation in other clinical studies in past 12 weeks. 10. Takes psychotropic medications that raise blood glucose (e.g. atypical antipsychotics)

Design outcomes

Primary

MeasureTime frame
1. Blood sugar fasting 2. Post Prandial Blood Sugar LevelTimepoint: 0th day, 91st day

Secondary

MeasureTime frame
1. Glycosylated haemoglobin (in %) â?? HbA1C 2. Quality of life 3. Ayurveda parameters such as Roga Bala, Agni Bala, Deha Bala, Chetas Bala 4. Reduction in the classical signs and symptoms of Prameha/ Madhumeha. 5. Urine routine and microscopic examination â?? albumin, sugar, casts/ crystals, epithelial cells, pus cells.Timepoint: 0th day, 91st day

Countries

India

Contacts

Public ContactDr Rama Kant Yadava

All India Institute of Ayurveda

mahtorajaram@yahoo.com8877033663

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026